ArticleWorld journal of surgical oncology2025
Real-world efficacy of postoperative adjuvant EGFR-TKI therapy for stage IA2-IA3 lung adenocarcinoma with high-risk pathological factors.
Sida Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.